Sigma Planning Corp Has $482,000 Holdings in Cardinal Health, Inc. (NYSE:CAH)

Sigma Planning Corp decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 23.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,778 shares of the company’s stock after selling 1,426 shares during the period. Sigma Planning Corp’s holdings in Cardinal Health were worth $482,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CAH. Ameriprise Financial Inc. increased its holdings in Cardinal Health by 82.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock worth $358,390,000 after purchasing an additional 1,862,291 shares in the last quarter. Northern Trust Corp boosted its position in shares of Cardinal Health by 0.9% during the third quarter. Northern Trust Corp now owns 3,340,547 shares of the company’s stock worth $290,026,000 after buying an additional 28,412 shares during the period. Pacer Advisors Inc. grew its holdings in shares of Cardinal Health by 17.5% during the fourth quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company’s stock worth $264,052,000 after buying an additional 389,431 shares in the last quarter. AQR Capital Management LLC raised its position in Cardinal Health by 0.8% in the 3rd quarter. AQR Capital Management LLC now owns 2,496,531 shares of the company’s stock valued at $216,749,000 after buying an additional 19,287 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its position in Cardinal Health by 2.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,149,131 shares of the company’s stock valued at $99,768,000 after buying an additional 32,892 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CAH shares. SVB Leerink began coverage on Cardinal Health in a research report on Monday, February 26th. They set an “outperform” rating and a $125.00 price target for the company. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday. UBS Group raised their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Barclays began coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price target on the stock. Finally, Leerink Partnrs restated an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $103.07.

Cardinal Health Price Performance

Cardinal Health stock opened at $103.81 on Friday. The company’s 50-day moving average is $109.54 and its 200-day moving average is $104.58. The firm has a market capitalization of $25.25 billion, a PE ratio of 40.87, a P/E/G ratio of 1.00 and a beta of 0.68. Cardinal Health, Inc. has a fifty-two week low of $77.56 and a fifty-two week high of $116.04.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. The firm had revenue of $57.45 billion for the quarter, compared to the consensus estimate of $57.02 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.32 earnings per share. As a group, analysts expect that Cardinal Health, Inc. will post 7.28 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a $0.5006 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is presently 78.74%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.